|
Novel Modalities for the Treatment of Cryptococcal Meningitis
This invention is the repurposing of oxfendazole, an FDA-approved veterinary anthelmintic benzimidazole and its novel oral bioavailability enhancing formulations for the oral treatment of cryptococcal meningitis. The oxfendazole ionic liquid containing nano formulations can lead to the development of low-cost oral treatment for cryptococcal meningitis.
Background:...
Published: 6/21/2024
|
Inventor(s): Abhijit Date, Yogesh Sutar, Kirsten Nielsen, Sophie Fulton
Keywords(s):
Category(s): Technology Classifications > Healthcare Portfolios > Infectious Diseases, Technology Classifications > Life Sciences > Therapeutics, Technology Classifications > Life Sciences > Drug Delivery
|
